News

Twenty-seven states, including Illinois and Wisconsin, and the District of Columbia on Monday filed a lawsuit in bankruptcy ...
The states argue that customers should have control over their personal information, which cannot be treated like ordinary ...
D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...
WASHINGTON — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block ...
Bankrupt DNA testing company 23andMe Holding (OTC:MEHCQ) is set to hold a second auction to sell its assets, including ...
Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy ...
The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...
The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...
Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...
The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...